Trade Mark Journal No.2025/021 23 May 2025

WO0000001853041 (10)

Office of origin: United States of America

Date of International Registration:2 April 2025
Date of designation in the UK: 2 April 2025
Image for mark 1853041 RSWITCH

International priority date claimed: 10 October 2024 (United States of America) (98794431)
Class 10
Synthetic RNA apparatus to control the expression of transgenes for use in cell and gene therapy.

Rgenta Therapeutics, Inc.

Representative: Jessica L. Rothstein Goodwin Procter LLP, 620 Eighth Avenue, New York NY 10018, UNITED STATES OF AMERICA